Group Exercise, Nutrition Aids Prostate Cancer Patients on ADT

Share this content:
Group Exercise, Nutrition Aids Prostate Cancer Patients on ADT
Group Exercise, Nutrition Aids Prostate Cancer Patients on ADT

TUESDAY, April 10, 2018 (HealthDay News) -- Men on androgen-deprivation therapy (ADT) for prostate cancer may significantly benefit from a group exercise and nutrition program, according to a study published online March 5 in the Annals of Behavioral Medicine.

Brian C. Focht, Ph.D., from The Ohio State University in Columbus, and colleagues randomized 32 prostate cancer patients undergoing ADT to the 12-week Individualized Diet and Exercise Adherence Pilot Trial or standard care. The intervention included a group-mediated, cognitive-behavioral exercise and dietary intervention (EX+D).

The researchers found that adherence and retention rates were good and there were no serious intervention-related adverse events reported. At the three-month follow-up, EX+D resulted in significantly greater improvements in mobility performance (P < 0.02), muscular strength (P < 0.01), body fat percentage (P < 0.05), and fat mass (P < 0.03), when controlling for baseline and androgen-deprivation therapy duration.

"Collectively, these results suggest that the EX+D was a safe and well-tolerated intervention for prostate cancer patients on ADT," the authors write. "The utility of implementing this approach in the treatment of prostate cancer patients on ADT should be evaluated in future large-scale efficacy trials."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Increase Seen in Salmonella Illnesses From Ground Beef

CDC: Increase Seen in <i>Salmonella</i> Illnesses From Ground ...

246 people now sickened; 59 people have been hospitalized; no deaths reported to date

Epinephrine Personal Autoinjectors Cost-Effective at 24

Epinephrine Personal Autoinjectors Cost-Effective at &#36;24

Based on 10-fold fatality risk difference, value-based price for personal epinephrine $24

Burden of Liver Cancer Rising in Medicare Patients

Burden of Liver Cancer Rising in Medicare Patients

Coexistence of other liver conditions tied to even higher risk for death, health care costs

is free, fast, and customized just for you!




Already a member?

Sign In Now »